• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    Newsroom

    ​12/9/2014
     

     

     

    DHMH partners with pharmacies to stock overdose-reversing Naloxone​

    Baltimore, MD (December 9, 2014) – The Department of Health and Mental Hygiene (DHMH) today announced a partnership with Walgreens, CVS Health, Safeway and other pharmacies to stock Naloxone in stores across Maryland and to train their pharmacists on Naloxone administration. Naloxone, also known by its brand name Narcan, is a life-saving medication that can quickly restore the breathing of a person who has overdosed on heroin or prescription opioids.

    “This partnership with CVS Health, Walgreens, Safeway and other independent pharmacies will help save lives,” said Joshua M. Sharfstein, Secretary of the Maryland Department of Health and Mental Hygiene. “Clinicians can now write prescriptions for this life-saving medication, knowing that it is available across the state.” 

    It was recently shared with DHMH that a 19-year-old Baltimore woman filled a prescription for Naloxone at her local pharmacy after witnessing a loved one die from an overdose. She used the medication when a 24-year-old was overdosing in her neighborhood, and someone knocked on her door asking for help. Her administration of Naloxone saved their life. 

    Maryland has been promoting greater access to Naloxone for residents across the state in response to rising numbers of overdose deaths. DHMH has written to providers encouraging them to write prescriptions for Naloxone to patients who may be at risk of overdosing. DHMH also has made it easier for Medicaid patients to obtain Naloxone by removing pre-authorization requirements, and DHMH has launched theOverdose Response Program, which authorizes local entities to train and certify qualified individuals to recognize and respond to an opioid overdose by administering Naloxone.

    “We are pleased to partner with DHMH to promote the availability of Naloxone as part of our ongoing efforts to combat drug abuse,” said Papatya Tankut, RPh, Vice President of Pharmacy Affairs, CVS Health. “In addition to having Naloxone in stock at many of our pharmacies in Maryland, all CVS pharmacy locations in the state can order Naloxone for patients who have a prescription for this medication.”

    “Walgreens is committed to the communities that we serve and we’re pleased to work with the DHMH to help provide greater access to lifesaving medications for Maryland residents responding to overdosing situations,” said Jon Reitz, market pharmacy director, Walgreens.

    Safeway pharmacies will begin carrying Naloxone on January 2, 2015. Detailed information on which stores in Maryland are carrying Naloxone can be found at www.dhmh.maryland.gov/naloxone. DHMH encourages all pharmacies that are carrying Naloxone and not listed to contact DHMH at DHMH.HealthMD@maryland.gov.


     

    ###​